HSA
NUTX

Hussman Strategic Advisors’s Nutex Health NUTX Stock Holding History

Hussman Strategic Advisors’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2M Hold
21,000
– – 0.43% 105
2025
Q4 		$3.46M Buy
+21,000
New +$2.79M 0.84% 12

Other funds holding NUTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WC
Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return

Hussman Strategic Advisors's NUTX Position: Q1 2026 in Review

Hussman Strategic Advisors held its Nutex Health (NUTX) position steady in Q1 2026 at 21,000 shares worth $2M. The position accounts for 0.43% of the portfolio, ranked #105.

Hussman Strategic Advisors first reported a position in NUTX in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.46M in Q4 2025. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • Hussman Strategic Advisors held 21,000 shares of Nutex Health worth $2M as of Q1 2026.
  • Hussman Strategic Advisors left its Nutex Health share count unchanged in Q1 2026.
  • Nutex Health made up 0.43% of Hussman Strategic Advisors's portfolio in Q1 2026, its #105 holding.
  • Hussman Strategic Advisors first reported a position in Nutex Health in Q4 2025 and has held it in 2 quarters since.
  • Hussman Strategic Advisors's Nutex Health position peaked at $3.46M in Q4 2025.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Hussman Strategic Advisors's 13F filing for Q1 2026, filed 11 May 2026.